Clinical Trials Browser

Pancreatic Metastatic Cancer

Borderline Resectable Pancreatic Adenocarcinoma

Biliary Tract Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Esophageal Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Esophageal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Cholangiocarcinoma

Small Bowel Adenocarcinoma

Neoplasm Metastasis, Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Appendiceal Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Biliary Tract Neoplasms, Gastrointestinal Neoplasms

Pancreatic Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Adenocarcinoma

Pancreatic cancer, adult, Pancreatic Neoplasms

Pancreatic Neoplasms

Adenocarcinoma, Mucinous, Carcinoma, Signet Ring Cell

Colorectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Gastrointestinal Neoplasms

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma

Colorectal Neoplasms

Stomach Neoplasms

Locally Recurrent Rectal Cancer

Esophageal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Urachal cancer, Urinary Bladder Neoplasms, Urethral Neoplasms

Clinical Trials

PAMELA70

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

TOGAR

LyRICX

Toco-CoR

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

PROTECT

FRUITFUL

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

PANCREAS

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

METIMMOX

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

ICARuS

BBOpCo

STOPGAP

ERASE-CRC

VVSHIP

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

PANC

METIMMOX-2

CEIL

Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE

ARION

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

A Study in Adults With Untreated Acute Lymphoblastic Leukemia

NIFE

LIVERPEARL

BIG

Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Induction Chemotherapy for Locally Advanced Esophageal Cancer

A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant